These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 35056807)
1. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties. Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807 [TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination. Robaina Cabrera CL; Keir-Rudman S; Horniman N; Clarkson N; Page C Pulm Pharmacol Ther; 2021 Aug; 69():102047. PubMed ID: 34082108 [TBL] [Abstract][Full Text] [Related]
3. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900 [No Abstract] [Full Text] [Related]
4. Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota. Luz-Veiga M; Amorim M; Pinto-Ribeiro I; Oliveira ALS; Silva S; Pimentel LL; Rodríguez-Alcalá LM; Madureira R; Pintado M; Azevedo-Silva J; Fernandes J Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768709 [TBL] [Abstract][Full Text] [Related]
5. Modulation of Redox and Inflammatory Signaling in Human Skin Cells Using Phytocannabinoids Applied after UVA Irradiation: In Vitro Studies. Wroński A; Jarocka-Karpowicz I; Surażyński A; Gęgotek A; Zarkovic N; Skrzydlewska E Cells; 2024 Jun; 13(11):. PubMed ID: 38891097 [TBL] [Abstract][Full Text] [Related]
6. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454 [TBL] [Abstract][Full Text] [Related]
7. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979 [TBL] [Abstract][Full Text] [Related]
8. The Origin and Biomedical Relevance of Cannabigerol. Jastrząb A; Jarocka-Karpowicz I; Skrzydlewska E Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887277 [TBL] [Abstract][Full Text] [Related]
9. Phytocannabinoids regulate inflammation in IL-1β-stimulated human gingival fibroblasts. Abidi AH; Abhyankar V; Alghamdi SS; Tipton DA; Dabbous M J Periodontal Res; 2022 Dec; 57(6):1127-1138. PubMed ID: 36070347 [TBL] [Abstract][Full Text] [Related]
10. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure. Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780 [TBL] [Abstract][Full Text] [Related]
11. Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes. di Giacomo V; Chiavaroli A; Recinella L; Orlando G; Cataldi A; Rapino M; Di Valerio V; Ronci M; Leone S; Brunetti L; Menghini L; Zengin G; Ak G; Abdallah HH; Ferrante C Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443623 [TBL] [Abstract][Full Text] [Related]
12. In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid. Gugliandolo A; Pollastro F; Grassi G; Bramanti P; Mazzon E Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986533 [TBL] [Abstract][Full Text] [Related]
13. Anti-Inflammatory Effects of Cannabigerol in Rheumatoid Arthritis Synovial Fibroblasts and Peripheral Blood Mononuclear Cell Cultures Are Partly Mediated by TRPA1. Lowin T; Tigges-Perez MS; Constant E; Pongratz G Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614296 [TBL] [Abstract][Full Text] [Related]
14. The antinociceptive activity and mechanism of action of cannabigerol. Wen Y; Wang Z; Zhang R; Zhu Y; Lin G; Li R; Zhang J Biomed Pharmacother; 2023 Feb; 158():114163. PubMed ID: 36916438 [TBL] [Abstract][Full Text] [Related]
15. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews. Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Cannabidiol on UV-Induced Changes in Intracellular Signaling of 3D-Cultured Skin Keratinocytes. Gęgotek A; Atalay S; Rogowska-Wrzesińska A; Skrzydlewska E Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540902 [TBL] [Abstract][Full Text] [Related]
17. Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation. Vacek J; Vostalova J; Papouskova B; Skarupova D; Kos M; Kabelac M; Storch J Free Radic Biol Med; 2021 Feb; 164():258-270. PubMed ID: 33453360 [TBL] [Abstract][Full Text] [Related]
18. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. Peschel W; Politi M Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837 [TBL] [Abstract][Full Text] [Related]
19. Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol. Mammana S; Cavalli E; Gugliandolo A; Silvestro S; Pollastro F; Bramanti P; Mazzon E Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31752240 [No Abstract] [Full Text] [Related]
20. Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris. Jarocka-Karpowicz I; Biernacki M; Wroński A; Gęgotek A; Skrzydlewska E Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32121131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]